PUBLICATIONS

1. Elmajian DA, Agha AH, Culkin DJ: Metastatic prostate cancer: an update.(review article). Hospital Medicine (August 1997).

2. Oesterling JE, Roy JB, Agha AH, Shown T, Karup T, Johansen T et al and Finasteride PSA Study group. Biologic variability of prostate specific antigen and its usefulness as a marker for prostate cancer: effects of Finasteride. Urology July 1997

3. Culkin DJ, Agha AH: Prostate Cancer: an update (review article). Hospital Medicine (May 1997).

4. Agha AH, Schechter EJ, Roy JB, Culkin DJ: Prostate specific antigen is metabolized in the liver. J. Urol., 155: 1332-35, April 1996

5. Agha AH, Culkin DJ, Bane BL: Cystic Carcinoma of the Prostate. J Ultrasound Med 15:75-77, 1996

6. Agha AH: Circumcision: History and trends. Bulletin, Oklahoma County Medical Association Feb 1996

7. Agha AH, Roy JB, Culkin DJ, Lyon K. The impact of 5 reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Advances in therapy. Vol. 12, No. 6:361-366, Nov/Dec 1995

8. Agha AH: Death, Law and Ethics. Bulletin, Oklahoma County Medical Association Jan 1993

ABSTRACTS/PRESENTATIONS:

1. Agha AH, Morgan SC, Archer SA, Wendelken JR,Culkin DJ: Bacillus calmette-guerin granuloma of the kidney following intravesical therapy for transitional cell carcinoma: case report. (To be presented at 76th South Central Section annual meeting, Nov. 1997)

2. Agha AH, Elmajian DA and Culkin DJ: Prostate specific antigen levels are subnormal in patients with cirrhosis of the liver (To be presented at 76th South Central Section annual meeting, Nov. 1997)

3. Agha AH, Roy JB, Culkin DJ: The durability of response and satisfaction with vacuum device for erectile dysfunction. J. Urol., 156:A, April 1997

4. Agha AH, Roy JB, Culkin DJ: The efficacy and satisfaction with vacuum device for erectile dysfunction. Abstract # 92, p 214, 75th annual meeting of south central section of AUA, Vail, Colorado, Sep 1996.

5. Roy JB, Petrone RL, Agha AH: Comparative pharmacodynamics and hemodynamics of the topical application to the penis of a new aqueous nitroglycerin gel versus nitroglycerin ointment in healthy male volunteers. Abstract #94, p 216, 75th annual meeting of south central section of AUA, Vail, Colorado, Sep. 1996.

6. Agha AH, Culkin DJ: Lymphedema of the male genitalia: case report: Abstract # 112, p 234, 75th annual meeting of south central section of AUA, Vail, Colorado, Sep. 1996.

7. Agha AH, Schechter EJ, Roy JB, Culkin DJ: Prostate specific antigen is metabolized in the liver: J. Urol., 155: 272A, May 1996

8. Roy JB, Petrone RL, Agha AH: A double-blind, placebo controlled trial of the hemodynamic effects of topical application to the penis of an aqueous nitroglycerin gel in healthy male volunteers. J. Urol., 155: 742A, May 1996

9. Agha AH, Roy JB, CULKIN DJ: The ideal way to measure the height of the prostate for transrectal ultrasonographic volumetry. J. Urol., 153: 301A, April 1995

10. Petrone RL, Agha AH, Roy JB: Urodynamic findings in patients with interstitial cystitis. J. Urol., 153: 290A, April 1995

11. Roy JB, Petrone RL, Agha AH: Comparative pharmacodynamics and hemodynamics of the topical application to the penis of a new aqueous nitroglycerin gel versus nitroglycerin ointment in healthy male volunteers. D 90 Int. J Impotence Res. (1994) 6, Suppl.